Acute kidney injury (AKI) affects 0.5--5.2% of joint replacement recipients and it is an independent risk factor for chronic renal impairment, increased morbidity, and death (Ympa et al. [@C24], Jafari et al. [@C11], Coca et al. [@C7], Kimmel et al. [@C13], Perregaard et al. [@C20]). AKI increases in-hospital mortality but the adverse effects of AKI can also occur late (Lafrance and Miller [@C14]).

The preoperative risk factors associated with postoperative AKI in arthroplasty patients include elevated body mass index (BMI), diabetes mellitus, chronic obstructive pulmonary disease, liver disease, congestive heart failure, hypertension, and vascular diseases (Jafari et al. [@C11], Weingarten et al. [@C23], Bell et al. [@C5]). Also, age, preoperative kidney dysfunction, and the preoperative use of renin-angiotensin axis-blocking medication are associated with postoperative AKI in arthroplasty patients (Aveline et al. [@C2], Kimmel et al. [@C13], Nielson et al. [@C18], Bell et al. [@C5]). Although the American Society of Anesthesiologists' (ASA) physical status classification system has a connection with AKI in orthopedic patients (Bell et al. [@C5]), it is not associated with AKI in arthroplasty patients (Jafari et al. [@C11], Kimmel et al. [@C13]).

Perioperative factors associated with AKI include general anesthesia and blood transfusions (Weingarten et al. [@C23]). Also, duration of operation has been reported to be longer in AKI patients, but not statistically significantly so (Jafari et al. [@C11], Weingarten et al. [@C23], and Kimmel et al. [@C13]). The effects of non-steroidal anti-inflammatory drugs and concomitant use of diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in arthroplasty populations is unclear (Lee et al. [@C16], Fournier et al. [@C10]). Aminoglycosides (such as gentamycin) that are used as intravenous antibiotic prophylaxis or in cement may trigger AKI because of their nephrotoxicity (Curtis et al. [@C8], Patrick et al. [@C19], Lau and Kumar [@C15], Ross et al. [@C21], Bell et al. [@C4], Craxford et al. [@C9], Johansson et al. [@C12]) but otherwise, there are no data on the conditions or underlying reasons that trigger postoperative AKI in arthroplasty patients.

We assessed the incidence and factors associated with AKI following hip and knee arthroplasty in a large Scandinavian cohort and report the specific conditions associated with AKI. We hypothesized that: (1) the Scandinavian population would have similar rates of AKI to those in other populations; and (2) the ASA classification system (as a measure of comorbidity) and duration of operation would show an association with AKI.

Patients and methods {#s0002}
====================

The study was performed in a large publicly funded orthopedic hospital specialized in joint replacement surgery, with an annual number of arthroplasties exceeding 3,000. The study population comprised patients with hip or knee arthroplasties performed at the hospital between September 2002 and December 2011 (n = 20,575). 2,000 patients were excluded from the study ([Figure 1](#F0001){ref-type="fig"}). The remaining 18,575 patients were used for the analyses. Demographic data and patient information were obtained from a prospective joint replacement database and patient administration database. The following data were collected for analysis: sex, age, indication for operation, BMI, ASA classification, anesthesia modality, prophylactic antibiotic, operated joint (hip or knee), duration of operation, fixation method (cemented, cementless, hybrid), laterality (unilateral or bilateral operation), type of operation (primary or revision), and use of antibiotic-impregnated bone cement ([Tables 1](#TB1){ref-type="table"} and [2](#TB2){ref-type="table"}).

![Exclusion of patients.](iort-88-370.F01){#F0001}

###### 

Association between preoperative factors and AKI; univariable regression results

  Descriptor                                                           All patients[^a^](#TF1){ref-type="table-fn"}   AKI              non-AKI          Incidence per 1,000 operations   OR (95% CI)                                 p-value
  -------------------------------------------------------------------- ---------------------------------------------- ---------------- ---------------- -------------------------------- ------------------------------------------- ----------
  Age, median (range)                                                  69 (14--102)                                   76 (41--88)      69 (14--102)                                      1.05 (1.02--1.08)                           0.001
  Sex                                                                                                                                                                                                                                
   Female                                                              11,650 (63)                                    33               11,617           2.8                              Reference                                   
   Male                                                                6,925 (37)                                     25               6,900            3.6                              1.3 (0.76--2.1)                             0.4
  Body mass index                                                                                                                                                                                                                    
   (missing, n = 1,719) median, (range)                                28.6 (14--59)                                  31.6 (24--43)    28.6 (14--59)                                     1.1 (1.0--1.1)                              0.001
   \< 25                                                               3,551 (21)                                     6                3,545            1.7                              Reference                                   
   25--30                                                              6,760 (40)                                     14               6,746            2.1                              1.2 (0.47--3.2)                             0.7
   30--35                                                              4,496 (27)                                     14               4,482            3.1                              1.9 (0.71--4.8)                             0.2
   \> 35                                                               2,049 (12)                                     12               2,037            5.9                              3.5 (1.3--9.3)                              0.01
  Joint                                                                                                                                                                                                                              
   Hip                                                                 8,821 (47)                                     23               8,798            2.6                              Reference                                   
   Knee                                                                9,754 (53)                                     35               9,719            3.6                              1.4 (0.8--2.3)                              0.2
   ASA classification (missing, n = 132)                                                                                                                                                                                             
   1                                                                   1,477 (8)                                      0                1,477            0.0                                                                          
   2                                                                   8,427 (46)                                     9                8,418            1.1                              Reference[^b^](#TF2){ref-type="table-fn"}   \< 0.001
   3                                                                   8,046 (44)                                     40               8,006            5.0                              5.5 (2.7--11)                               \< 0.001
   4                                                                   492 (3)                                        7                485              14.4                             16 (5.9--43)                                \< 0.001
   Preoperative SCr                                                    70 (25--1,125)                                 78 (49--150)     70 (25--1,125)                                    1.004 (1.00--1.01)                          0.007
   Preoperative eGFR, median (range)[^c^](#TF3){ref-type="table-fn"}   85 (3--160)                                    68 (30--108)     85 (3--160)                                       0.97 (0.95--0.98)                           \< 0.001
    1 (\> 90 mL/min)                                                   6,519 (35)                                     9                6,510            1.4                              Reference                                   
    2 (60--89 mL/min)                                                  9,917 (53)                                     29               9,888            2.9                              2.1 (1.0--4.5)                              0.05
    3 (30--59 mL/min)                                                  2,023 (11)                                     19               2,004            9.4                              6.9 (3.1--15)                               \< 0.001
    4 (15--29 mL/min)                                                  81 (0.4)                                       1                80               12.5                             9.0 (1.1--72)                               0.04
    5 (\< 15 mL/min)                                                   35 (0.2)                                       0                35               0                                --                                          --
  Preoperative hemoglobin, (missing, n = 72)                                                                                                                                                                                         
   median (range)                                                      138 (76--189)                                  135 (103--163)   138 (80--189)                                     0.97 (0.95--0.99)                           0.001
  Preoperative anemia[^d^](#TF4){ref-type="table-fn"}                                                                                                                                                                                
   No                                                                  16,423 (88)                                    47               16,376           2.9                              Reference                                   
   Yes                                                                 2,080 (11)                                     11               2,069            5.3                              1.9 (0.96--3.6)                             0.07
  Diagnosis                                                                                                                                                                                                                          
   Primary osteoarthritis                                              15,467 (83)                                    47               15,420           3.0                              Reference                                   
    Other diagnosis                                                    3,073 (17)                                     10               3,063            3.3                              1.1 (0.54--2.1)                             0.8

In this column, numbers mean number of patients and percentage in parentheses unless otherwise stated.

ASA classes 1 and 2 were combined for the regression analysis.

eGFR calculated using CKD-EPI formula.

Anemia was defined as hemoglobin \<117 g/L in women and \<134 g/L in men.

###### 

Association between perioperative factors and AKI; univariable regression results

  Descriptor                                                                 All patients[^a^](#TF5){ref-type="table-fn"}   AKI          Non-AKI       incidence per 1,000 operations   OR (95% CI)        p-value
  -------------------------------------------------------------------------- ---------------------------------------------- ------------ ------------- -------------------------------- ------------------ ---------
  Operation type                                                                                                                                                                                           
   Primary                                                                   15,943 (85)                                    44           15,899        2.8                              Reference          
   Revision                                                                  2,632 (15)                                     14           2,618         5.3                              1.9 (1.1--3.5)     0.03
  Knee operation type                                                                                                                                                                                      
   Unicondylar                                                               607 (6)                                        1            606           1.7                              Reference          
   Total                                                                     9,147 (94)                                     34           9,113         3.7                              2.3 (0.31--17)     0.4
  Bilateral operation                                                                                                                                                                                      
   No                                                                        16,908 (91)                                    55           16,853        3.3                              Ref                
   Yes                                                                       1,667 (9)                                      3            1,664         1.8                              0.55 (0.17--1.8)   0.3
  Prothesis fixation method (missing n = 1,410)                                                                                                                                                            
   Cementless                                                                4,107 (24)                                     6            4,101         1.4                              Reference          0.2
   Hybrid                                                                    2,595 (15)                                     7            2,591         2.7                              1.9 (0.62--5.5)    0.3
   Total cement                                                              10,460 (61)                                    35           10,425        3.4                              2.3 (0.96--5.5)    0.06
  Use of antibiotic-impregnated bone cement (missing, n = 589)                                                                                                                                             
   Gentamycin                                                                11,764 (94)                                    40           11,724        3.4                                                 
   Tobramycin                                                                541 (4)                                        0            541           0                                                   
   Other                                                                     164 (1)                                        0            164           0                                                   
  Antibiotic prophylaxis (missing, n = 592)                                                                                                                                                                
   Cefuroxime                                                                17,714 (99)                                    48           17,666        2.7                              Reference          0.005
   Clindamicin                                                               207 (1)                                        3            204           14.7                             5.4 (1.7--17)      0.005
   Other                                                                     62 (0.3)                                       1            61            16.4                             6.0 (0.82--44)     0.08
  Anesthesia modality (missing, n = 105)                                                                                                                                                                   
   Spinal                                                                    2,077 (11)                                     4            2,073         1.9                              Reference          0.8
   Continuous spinal                                                         1,710 (9)                                      7            1,703         4.1                              6.3 (0.66--61)     0.2
   Combined spinal epidural                                                  14,302 (77)                                    44           14,258        3.1                              3.0 (0.41--23)     0.4
   General                                                                   287 (2.0)                                      1            286           3.5                              8.3 (0.52--133)    0.6
   Other                                                                     94 (0.5)                                       0            94            0                                                   1
  Duration of operation[^b^](#TF6){ref-type="table-fn"} (missing, n = 110)                                                                                                                                 
   median (range)                                                            10 (10--68)                                    12 (6--25)   10 (10--68)                                    1.0 (1.0--1.1)     0.07

In this column, numbers mean number of patients and percentage in parentheses unless otherwise stated.

Duration in 10-min intervals (time from incision to end of wound closure).

Pre- and postoperative serum creatinine (SCr) levels were obtained from the database of a local laboratory that provides our hospital, an adjacent university hospital, and the majority of the communities in the catchment area with laboratory services. The SCr level is routinely obtained as part of the pre-anesthesia evaluation carried out 1--2 months before the operation, but measurements taken within 6 months before the operation were approved. If multiple preoperative SCr measurements were recorded, the most recent SCr measurement was used. Postoperatively, SCr was measured for clinical indications only and not routinely. In our study, we took account of all postoperative SCr measurements taken ≤7 days after the operation, which was done in 5,609 operations (30%). These patients had lower eGFR preoperatively (76 mL/min/1.73 m^2^ vs 87 mL/min/1.73 m^2^), older mean age (76 years vs 67 years), higher ASA classification (median 3 vs. 2), and a slightly longer mean duration of operation (105 min vs. 100 min) than patients with no SCr measurement done during the first 7 postoperative days. Of these patients, 39% (2,210) were male and 22% (1,222) had revision arthroplasty. There were also 5,361 patients (29%) who lacked postoperative laboratory follow-up after discharge from our unit because their home county used a different laboratory. We included these patients in our analysis to maximize the number of AKI cases and therefore to maximize statistical power. As the characteristics of these patients differed slightly from those of the patients who were examined in our laboratory (data not shown), we excluded these patients from the sensitivity analysis to eliminate a possible source of bias.

We used SCr to classify all the patients into one of the RIFLE classifications (risk, injury, failure) or into a non-AKI group (Bellomo et al. [@C6]). We assumed that the patients who were not tested for postoperative SCr would not have had postoperative AKI. To maintain high specificity, those patients who were in the risk of AKI class were classified as not having AKI. We used preoperative SCr to calculate the estimated glomerular filtration rate (eGFR) using the CKD-EPI formula (Levey et al. [@C17]).

In patients who developed AKI (class I or F according to the RIFLE criteria), we reviewed the medical records in order to define the possible pre- and postoperative risk factors associated with AKI ([Table 4](#TB4){ref-type="table"}), and the outcome of AKI. We classified the outcome as spontaneous return of kidney function, loss of kidney function, or end-stage kidney disease.

###### 

Factors possibly contributing to development of AKI in 58 patients

  Risk factor                                               Frequency (missing)
  --------------------------------------------------------- ---------------------
  ASA class ≥3                                              47 (2)
  Baseline BP ≤80 mmHg[^a^](#TF9){ref-type="table-fn"}      14 (4)
  Blood transfusion                                         14 (5)
  BMI ≥30                                                   26 (12)
  Duration ≥120 min                                         30 (2)
  eGFR ≤90 mL/min                                           49
  Medication combination[^b^](#TF10){ref-type="table-fn"}   10 (9)
  Perioperative NSAIDs                                      20 (9)
  Preoperative anemia[^c^](#TF11){ref-type="table-fn"}      11
  Use of vasoactives[^d^](#TF12){ref-type="table-fn"}       22 (4)

Perioperative blood pressure.

Concomitant use of 3 or more of the following drugs in perioperative period: diuretics, angiotensin-converting enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs), NSAIDs.

Anemia was defined as hemoglobin \<117 g/L in women and \<134 g/L in men.

Atropine or etilefrine.

Statistics {#s0003}
----------

For the statistical analyses, we identified the AKI cases using the criteria described above. Furthermore, we used all the non-AKI patients as a control group. 95% confidence interval (CI) for the incidence rate of postoperative AKI was calculated using the Wilson score interval. The relationship between potential risk factors and AKI was analyzed using univariable binary logistic regression. Multivariable binary logistic regression analysis was performed using the enter method to minimize bias. To create a multivariable model, we used a directed acyclic graph (DAG) to establish a causal relationship between variables and to find a minimal adjustment set to minimize bias. Due to the complexity of the causal relationships among all variables associated with AKI, we used the Dagitty tool (Textor et al. [@C22]) to create the multivariable model. We chose duration of operation as an exposure variable and AKI as an outcome variable. The Dagitty model showed that BMI, fixation technique, bilateral operation, and operation type and joint was the minimal sufficient adjustment set to minimize bias. We also included the ASA classifications and preoperative eGFR in the multivariable model according to clinical experience (see Supplementary data) and because these variables were interesting for our study hypothesis. We performed a sensitivity analysis that included only the minimal adjustment set to make sure that the results remained unchanged when the ASA classifications and eGFR were added to the model. A Kaplan-Meier analysis was performed to determine the effect of AKI on survival rates. The results were considered statistically significant when the p-value was \<0.05. As the incidence of AKI is very low, all the odds ratios provided can be interpreted as relative risk (RR) unless otherwise stated. We used SPSS 21 software for the statistical analysis.

Ethics {#s0004}
------

In Finland, ethical committee approval is not required in retrospective studies with no human subjects, such as this one. The study was accepted by Pirkanmaa hospital district (ETL-code 13501) on Mar 1, 2013.
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Results {#s0006}
=======

58 cases of AKI were identified in 18,575 patients. Among the 13,214 patients whose specimens were tested by our hospital laboratory, 44 AKI cases were identified and the incidence of AKI was 3.3 per 1,000 operations (95% CI: 2.5--4.5). Of the 58 patients with AKI, 43 had injury- and 15 had failure-stage AKI. In univariable analysis, the risk factors for AKI preoperatively were age, BMI, ASA classification, SCr, eGFR, and hemoglobin value ([Table 1](#TB1){ref-type="table"}), and perioperatively the risk factors were operation type and intravenous antibiotic prophylaxis ([Table 2](#TB2){ref-type="table"}). The multivariable model showed that duration of operation, ASA classification, BMI, and preoperative eGFR were independent risk factors for postoperative AKI ([Table 3](#TB3){ref-type="table"}).

###### 

Multivariable regression results

  Descriptor                                              OR (95% CI)        p-value
  ------------------------------------------------------- ------------------ ----------
  Duration of operation[^a^](#TF7){ref-type="table-fn"}   1.1 (1.0--1.2)     0.003
  ASA classification                                                         
   1 and 2                                                Reference          
   3                                                      4.4 (1.8--11)      0.002
   4                                                      13 (3.7--46)       \< 0.001
  Bilaterality                                                               
   Unilateral                                             Reference          
   Bilateral                                              0.31 (0.06--1.6)   0.2
  Body mass index                                         1.1 (1.0--1.1)     0.02
  Fixation technique                                                         
   Cementless                                             Reference          
   Hybrid                                                 1.7 (0.56--5.1)    0.3
   Total cement                                           1.2 (0.39--3.7)    0.8
  Joint                                                                      
   Hip                                                    Ref                
   Knee                                                   1.0 (0.43--2.5)    1
  Operation type                                                             
   Primary                                                Reference          
   Revision                                               0.46 (0.12--1.7)   0.2
  Preoperative eGFR[^b^](#TF8){ref-type="table-fn"}       0.98 (0.97--1.0)   0.03

Duration in 10-min intervals (from incision to end of wound closure).

eGFR calculated using CKD-EPI formula.

Sensitivity analysis was performed to determine whether these results were also valid in the primary arthroplasty group (n = 15,943). Multivariable analysis demonstrated the same independent risk factors for AKI as identified in the original analysis. We also repeated the analysis with adjustment for only the variables in the minimal sufficient adjustment set, and the results remained unchanged, confirming that both duration of operation and BMI were independent risk factors for AKI. In the third sensitivity analysis, we excluded all 5,361 patients (14 of 58 AKI cases) with a different laboratory register in their community and thus possibly lacking a 7-day postoperative laboratory follow-up. This analysis showed the same independent risk factors for AKI.

A potential cause of AKI was identified in 28 cases. The most common conditions were postoperative infections in 15 patients, cardiac causes in 5 patients, and pseudo-obstruction in 5 patients. In 28 cases, no specific cause could be identified retrospectively. Most patients had several factors that possibly contributed to the development of AKI ([Table 4](#TB4){ref-type="table"}). 2 of the AKI patients had no patient records concerning the postoperative period, so the reason for AKI could not be found. 2 patients with AKI underwent postoperative dialysis for less than 4 weeks and both recovered their kidney function. Thus, neither of these patients was classified in the loss of kidney function group or the end-stage kidney disease group.

Mortality was substantially higher in AKI patients than in non-AKI patients throughout the follow-up ([Figure 2](#F0002){ref-type="fig"}).

![Survival curve, with all-cause mortality as endpoint.](iort-88-370.F02){#F0002}

Discussion {#s0007}
==========

Despite the fact that preoperative kidney dysfunction according to eGFR is common in our Scandinavian population (65% of the patients had eGFR \<90 mL/min), AKI is rare (with an incidence of 3.3 per 1,000 arthroplasties). We found that duration of operation, preoperative eGFR, ASA class, and BMI were all independent risk factors for postoperative AKI. However, half of all cases of AKI occurred without any underlying cause identified. The survival of patients with AKI was worse than that of non-AKI patients.

The incidence of AKI was lower than that reported by other groups (3.3 per 1,000 vs. 5.5 per 1,000 vs. 52 per 1,000) (Jafari et al. [@C11], Kimmel et al. [@C13]). This might be due to lower BMI (29 vs. 32 and 31), a smaller proportion of general anesthesia (1.5% vs. 6.1% and 60%), a larger proportion of ASA class 1 patients (8.0% vs. 4.8% and 2.8%), and shorter duration of operation (100 min vs 157 min vs 119 min) in our cohort compared to the other cohorts (Jafari et al. [@C11], Kimmel et al. [@C13]). The incidence of AKI was lower compared to Perregaard et al. [@C20] (3.3 per 1,000 vs. 21.9 per 1,000). Unlike in our study, they included mild-stage AKI in their analysis, which probably explains the difference.

We found that BMI was an independent risk factor for AKI, a finding supported by previous studies (Jafari et al. [@C11]. Kimmel et al. [@C13]). An association has also been shown between lower eGFR and AKI (Jafari et al. [@C11], Kimmel et al. [@C13], Bell et al. [@C5]). In univariable analysis, preoperative renal impairment increased doubled the risk of AKI by 2-fold, when eGFR was lower than 90 mL/min and increased it by 7-fold when eGFR was lower than 60mL/min. The indidence of AKI was higher following revision than after primary surgery, but the association was lost in multivariable analysis, probably because revision arthroplasty patients had more factors associated with AKI. In our population, patients undergoing revision arthroplasty generally had a longer duration of operation and a higher ASA class.

Some case reports have suggested that vancomycin-, tobramycin-, and gentamycin-impregnated bone cements may also induce AKI (Curtis et al. [@C8], Patrick et al. [@C19], Lau and Kumar [@C15], Johansson et al. [@C12]). In our study, aminoglycoside bone cement (94% gentamycin) was used in all patients and still we had a low rate of AKI. Furthermore, AKI rates were similar between cementless, hybrid, and fully cemented arthroplasties.

Our study validates ASA class as an independent risk factor for AKI in arthroplasty patients. This is in accordance with cohorts comprising patients undergoing a large variety of orthopedic operations, including various arthroplasties, fractures, and osteotomies (Bell et al. [@C5]). Previous studies on arthroplasty patients (Jafari et al. [@C11], Kimmel et al. [@C13]) again included multiple morbidities in the multivariable model alongside the ASA class, which might explain why ASA class was not a significant predictor of AKI in these studies. Our odds ratios in different ASA classes were high, and we suggest that readers should not interpret these results as relative risk.

We are the first group to find that duration of operation was a strong and independent risk factor for AKI. Other studies that have found an insignificant association between duration of operation and AKI were case-control studies with smaller control groups (Jafari et al. [@C11], Kimmel et al. [@C13]) or smaller cohort studies (Weingarten et al. [@C23]). In our study population, the incidence of AKI almost doubled when the duration of surgery exceeded 120 min. Clinical experience shows that prolonged surgery is usually caused by perioperative problems, and longer duration has plenty of associations with other perioperative factors (for example, blood transfusions, cooling, coagulopathies, and use of anesthetics) that could mediate AKI. However, the systemic inflammation caused by increased tissue damage due to the prolonged duration of the operation and prolonged tourniquet use could also be the explanation (Andres et al. [@C1], Basile et al. [@C3]).

Concerning antibiotic prophylaxis, earlier studies have shown an association between gentamycin and AKI (Ross et al. [@C21], Bell et al. [@C4], Craxford et al. [@C9], Johansson et al. [@C12]). In our cohort, gentamycin was rarely used. Instead of gentamycin, the secondary option for cefuroxime was clindamycin. However, in the AKI patients, only 3 patients received clindamycin, so significant results in univariable analysis concerning clindamycin should be viewed with caution.

Whenever AKI occurred, its outcome was good---with only 2 of the 58 AKI patients receiving dialysis, and neither of them for more than 4 weeks. This result is in accordance with the earlier literature. Jafari et al. ([@C11]) reported that 7 out of 98 of their AKI patients received dialysis, whereas Kimmel et al. ([@C13]) reported that none of their AKI patients (AKI stage I or F, n = 22) received dialysis postoperatively. Although resolution of kidney function was common, the survival of patients with AKI was surprisingly poor, which warrants further research.

In half of the cases, no specific cause or condition underlying the AKI was found. It is possible that a triggering factor for AKI in these patients might simply be the systemic stress caused by the operation. Post- or preoperative infection, paralytic ileus, and cardiac causes were remarkable factors underlying AKI and served to explain almost half of the AKI cases. By preventing these factors, it might be possible to reduce rates of AKI. We do, however, acknowledge that in some cases the factors leading to AKI could not be identified because of the retrospective nature of the study.

The strength of the present study was the relatively large patient cohort compared to previous studies. We used a full, unselected cohort as controls in our analysis. Moreover, the underlying causes of AKI have not been adequately reported before. The study also had some limitations. Because the records of some patients were not available, there was a lack of information on the underlying reasons for their AKI. As SCr was measured for clinical indications and not routinely in all patients, it is probable that some AKI cases were not identified. Thus, it is likely that more AKI cases would have been found if the SCr of all patients had been screened every day during the first postoperative week. In the earlier literature, not all postoperative SCr levels were recorded either (Jafari et al. [@C11]), so the results are comparable. Kimmel et al. ([@C13]) had postoperative SCr measured from every patient and reported remarkably higher rates of AKI than ours (52 per 1,000 vs. 3.3 per 1,000). In our study population, the incidence of AKI in patients for whom postoperative SCr was measured was much smaller (10 per 1,000 operations), although this incidence number is probably overstated due to selection bias.

In summary, we found that high rates of AKI might be prevented if the risk profile of patients is favorable. Contrary to our hypothesis, we found very low rates of AKI. The results suggest that the risk of developing AKI is elevated in patients with a duration of operation exceeding 120 min, higher BMI, ASA class ≥3, or impaired kidney function preoperatively (eGFR\< 90 mL/min). We therefore suggest careful renal monitoring postoperatively for patients with these risk factors, in order to identify AKI. It is important to find and optimize patients who are at risk of AKI already preoperatively, to prevent future kidney manifestations---and also to communicate the risk to the patient when considering a procedure aimed at improving quality of life in a high-risk patient.

Supplementary data {#s0008}
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A directed acyclic graph is available as supplementary data in the online version of this article, <http://dx.doi.org/10.1080/17453674.2017.1301743>.
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